20516 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof Esters of saccharides
Pentagalloyl glucose (PGG) for use in treatment of pulmonary hypertension
#2ALPHA POLYGLUTAMATED TETRAHYDROFOLATES AND USES THEREOF
#3CONTINUOUS FLOW METHODS FOR PRODUCING MANNOSE-1-PHOSPHATE, POLYMORPHS OF MANNOSE-1-PHOSPHATE, AND COMPOSITIONS AND USES RELATED THERETO
#4IP AND IP ANALOGS DOSAGE REGIMENS FOR THE TREATMENT OF ECTOPIC CALCIFICATIONS
#5COMPOSITIONS COMPRISING YEAST CELLS AND POLYPHENOLS AND THEIR USE
#6METHOD FOR TREATING ORAL CANCER
#7MINIMAL SAPONIN ANALOGUES, SYNTHESIS AND USE THEREOF
#8TRITERPENE SAPONINS, METHODS OF SYNTHESIS, AND USES THEREOF
#9Compounds for Anti-aging Intervention
#10RIBOSE LINKERS AND CONJUGATES THEREOF
#11COMPOSITIONS COMPRISING DIMOCARPUS EXTRACT FOR USE IN THE TREATMENT OR PREVENTION OF AN INFECTION CAUSED BY AN ENVELOPED VIRUS
#12Process for the preparation of sucrose octasulfate octakistriethylammonium salt (TASOS) powder and uses thereof
#13SUCRALFATE-CONTAINING JELLY-LIKE PHARMACEUTICAL COMPOSITION
#14USE OF IGF-2 RECEPTOR AGONIST LIGANDS FOR TREATMENT OF ANGELMAN SYNDROME AND AUTISM
#15ANTI-HUMAN NOROVIRUS AGENT
#16COMPOSITION AND METHODS FOR TREATING AN ANEURYSM
#17TRITERPENE SAPONIN ANALOGUES
#18Phenol Compound-Linked Pentagalloyl Glucose Derivatives and Uses Thereof
#19NEW SYNTHETIC AGONISTS OF TLR4 RECEPTOR
#20TANNIN-BASED ANTIPROLIFERATIVE PHARMACEUTICAL
#21VETERINARY FORMULATION OF METRONIDAZOLE, AND RELATED METHODS
#22CRYSTAL FORMS OF GLUCOSAMINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#23COMPOUNDS FOR TREATING OR PREVENTING ALZHEIMER'S DISEASE
#24NOVEL POLYPHENOL COMPOUND
#25NOVEL USE
#26MPLA COMPOSITIONS AND METHODS OF USE
#27T CELLS WITH REDUCED SURFACE FUCOSYLATION AND METHODS OF MAKING AND USING THE SAME
#28PHARMACEUTICAL COMPOSITIONS, COMPRISING A COMBINATION OF SELECT CARRIERS AND FLAVONOIDS AS ANTIPATHOGENS
#29TREATMENT OF HMGB1-MEDIATED INFLAMMATION
#30METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS
#31NEW COMPOSITIONS OF SUCRALFATE IN ALGINATE AND THEIR USE IN THERAPY
#32GUT MICROBIOTA AND TREATMENT OF CANCER
#33Triterpene saponin analogues
#34Tannin-based antiproliferative pharmaceutical
#35BRARTEMICIN ANALOGUES
#36Triterpene saponins, methods of synthesis and uses thereof
#37GLYCOLIPID COMPOSITIONS AND METHODS OF USE
#38COMPOSITIONS COMPRISING YEAST CELLS AND POLYPHENOLS AND THEIR USE
#39Pentagalloyl Glucose Derived from Schinus Plants and Methods of Use
#40METHOD OF PREPARING PENTACYCLIC TRITERPENOID SAPONINS AND DRUG COMPOSITION
#41Small Molecule Agents, Compositions, and Formulations, for Internal Use, Displaying Inhibitory Activity Against Gram-positive and/or Gram-negative Organisms
#42Modified hexa-acylated neisserial LPS
#43Minimal saponin analogues, synthesis and use thereof
#44A COMPOSITION COMPRISING SIMETHICONE AND SUCROSE ESTERS AND USE THEREOF AS AN ANTIFOAM AGENT
#45Neurologist Formulated Nocturnal Nootropic Founded on a Novel Theory of Brain Aging
#46Composition for preventing gray hair, promoting black hair and preventing, improving or treating vitiligo or hypochromatism comprising fructose 1,6-bisphosphate or salt, solvate, stereoisomer or hydrate thereof as active ingredient
#47USE OF NOCARDIA RUBRA CELL WALL SKELETON IN TREATMENT OF THERMAL INJURY
#48METHOD FOR TREATING AMYLOIDOGENIC DISEASE
#49PREPARATIONS FOR THE PREVENTION OF ILLNESSES ACQUIRED VIA THE ORAL CAVITY AND PHARYNX
#50ACYLATED COMPOUNDS FOR THE TREATMENT OF OCULAR PATHOLOGIES
#51ANTI-HUMAN NOROVIRUS AGENT
#52PEROXIDE REMOVAL FROM DRUG DELIVERY VEHICLE
#53Esters of 2-deoxy-monosaccharides with anti proliferative activity
#54CARBON NANOTUBE COMPOSITE VECTOR HAVING SYNERGISTIC EFFECT OF PHOTOTHERMAL THERAPY AND GENE THERAPY, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#55ALPHA POLYGLUTAMATED TETRAHYDROFOLATES AND USES THEREOF
#56Pharmaceutical Compositions, Comprising a Combination of Select Carriers and Flavonoids as Antipathogens
#57THERAPY FOR NEUROLOGICAL DISEASES/DISORDERS
#58SELF-MICELLIZING FATTY ACIDS AND FATTY ACID ESTER COMPOSITIONS AND THEIR USE IN THE TREATMENT OF DISEASE STATES
#59SICKLE CELL DISEASE TREATMENT UTILIZING OMEGA-3 FATTY ACIDS
#60Use of IGF-2 receptor agonist ligands for treatment of Angelman Syndrome and autism
#61NOVEL TLR4 INHIBITORS FOR THE TREATMENT OF HUMAN INFECTIOUS AND INFLAMMATORY DISORDERS
#62Adipocyte-targeting DNA nanodrug and preparation and uses thereof
#63IP and IP analogs dosage regimens for the treatment of ectopic calcifications
#64Use of UAP inhibitors to inhibit flux through the hexosamine biosynthetic pathway
#65METHODS OF INHIBITION OF PROTEIN FUCOSYLATION IN VIVO USING FUCOSE ANALOGS
#66METHOD FOR TREATMENT OF CANCER
#67Brartemicin analogues
#68Compositions and methods for treatment of inflammatory disorders
#69Minimal saponin analogues, synthesis and use thereof
#70Treatment of HMGB1-mediated inflammation
#71Mofezolac derivatives as multi-functions selective COX-1 inhibitors
#72Crocin-sorafenib combination therapy for liver cancer
#73PURE HEPTASULFATED DISACCHARIDES HAVING IMPROVED ORAL BIOAVAILABILITY
#74TRITERPENE SAPONIN ANALOGUES
#75Compositions containing tannic acids and uses thereof
#76Method for preventing the formation of calcified deposits and for inactivating xenoantigens in biological matrices
#77Formulations for Treating and/or Preventing Disease
#78PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PROSTATIC HYPERPLASIA
#79MEDICAL APPLICATION OF COMPOSITION OF FRUCTOSE-1,6-BISPHOSPHATE AND BLOOD CONCENTRATION STABILIZER THEREOF
#80Triterpene saponin analogues
#81Formulation comprising liposomes
#82IP and IP analogs dosage regimens for the treatment of ectopic calcifications
#83T cells with reduced surface fucosylation and methods of making and using the same
#84Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
#85Sickle cell disease treatment utilizing omega-3 fatty acids
#86Methods of inhibition of protein fucosylation in vivo using fucose analogs
#87Method of alleviating chronic wounds
#88Compositions Containing Enriched Natural Crocin and/or Crocetin, and Their Therapeutic or Nutraceutical Uses
#89Methods to reduce fat accumulation and oxidative damage in liver using green mango extracts and compounds obtained therefrom
#90TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
#91Peroxide removal from drug delivery vehicle
#92Gut microbiota and treatment of cancer
#93Prebiotic composition containing butyryl-fructooligosaccharides
#94Herpes zoster vaccine composition
#95Glycolipid compositions and methods of use
#96Method for Treating Obesity
#97Article coatings including oligomerized polyphenol layer and biological methods of use
#98Acylated compounds for the treatment of ocular pathologies
#99Method of use of eritoran as a TLR4 antagonist for treatment of ebola and Marburg disease
#100GLA monotherapy for use in cancer treatment
#101Method for Treating Obesity
#102Esters of 2-deoxy-monosaccharides with anti proliferative activity
#103COMPOSITIONS FOR AND METHODS OF TREATING AND PREVENTING CANCER TARGETING TUMOR ASSOCIATED CARBOHYDRATE ANTIGENS
#104Formulations of cysteamine and cysteamine derivatives
#105COMPOSITIONS CONTAINING TANNIC ACIDS AND USES THEREOF
#106Pure heptasulfated disaccharides having improved oral bioavailability
#107Crocins compounds and uses thereof
#108Extract of undifferentiated cells of and uses thereof in dermo-cosmetics
#109Composition, crocins active site, and uses thereof
#110MOFEZOLAC DERIVATIVES AS MULTI-FUNCTIONS SELECTIVE COX-1 INHIBITORS
#111Saffron extract and its use for the prevention of mood disorders related to depression
#112PHASE 2 INDUCERS AND RELATED SIGNALING PATHWAYS PROTECT CARTILAGE AGAINST INFLAMMATION, APOPTOSIS AND STRESS
#113Small molecule agents, compositions, and formulations, for internal use, displaying inhibitory activity against gram-positive and/or gram-negative organisms
#114Modified hexa-acylated neisserial LPS
#115COMPOUNDS, COMPOSITIONS AND METHODS FOR PROTECTING BRAIN HEALTH IN NEURODEGENERATIVE DISORDERS
#116Treatment of HMGB1-mediated inflammation
#117Compositions for management of infections
#118TRITERPENE SAPONIN ANALOGUES
#119Use of Oligosaccharide Compounds for Activating Angiogenesis
#120Antibacterial agent against multidrug-resistant gram-positive bacteria and external agent
#121Compositions and methods for treatment of inflammatory disorders
#122Compositions and methods for borocarbohydrate complexes
#123PHARMACEUTICAL COMPOSITION FOR USE IN INHIBITING RECURRENCE, AGGRAVATION AND METASTASIS OF HEPATOCARCINOMA
#124Anticancer composition and use thereof
#125Application of ethyl p-methoxycinnamate and derivatives thereof in maintaining self-renewal and pluripotency of stem cells
#126Prevention and treatment of inflammatory conditions
#127Use of factor Xa inhibitors for regulating glycemia
#128Tyrosine kinase inhibition as a treatment for epilepsy
#129Use of UAP inhibitors to inhibit flux through the hexosamine biosynthetic pathway
#130Enrichment methods for preparing tannic acid compositions
#131Use of isothiocyanate derivatives as modulators of peripheral and neuropathic pain
#132Compositions containing tannic acids and uses thereof
#133Anti-viral azide containing compounds
#134Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and applications thereof
#135Controlled release of active substances
#136Crystalline difucosyllactose
#137Self assembled gels for controlled delivery of encapsulated agents to cartilage
#138Methods of modulating immune system responses
#139Triterpene saponins, methods of synthesis and uses thereof
#140NON-ANTICOAGULANT SULFATED OR SULFONATED SYNTHETIC POLYMERS
#141Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states
#142Vaccine adjuvant compositions
#143Lactic acid bacterial immunopotentiating activity-increasing composition and method for increasing immunopotentiating activity of lactic acid bacteria
#144Composition containing phytic acid, magnesium and polyphenols for the treatment or prevention of renal lithiasis
#145NON-TOXIC AGENT FOR A BROAD-SPECTRUM, BACTERICIDAL OR BACTERIOSTATIC TREATMENT OF ANTIBIOTIC-RESISTANT BACTERIA IN ANIMALS
#146Minimal saponin analogues, synthesis and use thereof
#147TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
#148HDC Activation Inhibitor, HDC Activation Inhibition Composition, Antipruritic Agent, and Antipruritic Agent Composition
#149SYNAPTOJANIN-2 INHIBITORS FOR USE IN THE TREATMENT OF CANCER
#150Methods of inhibition of protein fucosylation in vivo using fucose analogs
#151Compositions and methods for borocarbohydrate complexes
#152Multidrug-Resistant Gram-Positive Bacteria Antibacterial Agent and Topical Agent
#153Compounds, compositions and corresponding uses for preventing and/or treating of dyslipidemia
#154Compounds and compositions comprising such compounds for the prevention or treatment of dyslipidaemias
#155Use of novel monosaccharide-like glycylated sugar alcohol compositions for designing and developing anti-diabetic drugs
#156Compositions containing enriched natural crocin and/or crocetin, and their therapeutic or nutraceutical uses
#157Compositions for and methods of treating and preventing targeting tumor associated carbohydrate antigens
#158Esters of 2-deoxy-monosacharides with anti proliferative activity
#159Omega-3 fatty acid ester compositions unitary pharmaceutical dosage forms
#160Compositions and methods for borocarbohydrate complexes
#161ADMINISTRATION OF ERITORAN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF TO TREAT ORTHOMYXOVIRUS INFECTIONS
#162Short-chain fatty acid hexosamine analogs and their use in tissue engineering applications
#163Treatment of cystic diseases
#164Anti-viral azide containing compounds
#165Therapeutic Composition for the Treatment of Perianal Disorders
#166Use of a composition comprising avocado perseose in the protection of epidermal stem cells
#167GLA monotherapy for use in cancer treatment
#168Stable micelles of fatty acid esters for the treatment of disease states
#169Stable micelles of fatty acid esters for the treatment of macular degeneration and primary sclerosing cholangitis
#170Stable micelles of fatty acid esters for the treatment of non-alcoholic fatty liver diseases
#171Stable micelles of fatty acid esters for the treatment of cardiovascular disease
#172Functional foods and kits containing stable micelles of fatty acid esters
#173Stable micelles of fatty acid esters
#174Stable micelles of mixed fatty acids
#175Methods of improving RNAi in well-differentiated airway epithelia
#176SYNBIOTIC COMPOSITION AND USE THEREOF
#177Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
#178TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
#179Treatment of sickle cell disease and inflammatory conditions
#180Granular material for orally fast disintegrating tablets
#181FRUCTOSE ABSORPTION INHIBITOR
#182Use of monosaccharide-like glycylated sugar alcohol compositions for designing and developing anti-diabetic drugs
#183Methods for introducing mannose 6 phosphate and other oligosaccharides onto glycoproteins and applications thereof
#184HDC Activation Inhibitor, HDC Activation Inhibition Composition, Antipruritic Agent, and Antipruritic Agent Composition
#185COMPOUNDS REDUCING THE PRODUCTION OF SORBITOL IN THE EYE AND METHODS OF USING THE SAME
#186Compounds, compositions and methods for protecting brain health in neurodegenerative disorders
#187Methods for inhibiting advanced glycation end product production, inhibiting fibroblast apoptosis, and/or promoting human fibroblast-collagen grating formulation using cherry blossom and cherry leaf extract
#188COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR AND NEUROLOGICAL DISEASES
#189Attractant for bone marrow stem cells and method for attracting bone marrow stem cells
#190Pharmaceutical composition comprising sophorolipid in combination with an antibiotic
#191Compositions and methods for reducing or preventing metastasis
#192Triterpene saponins, methods of synthesis and uses thereof
#193Omega-3 fatty acid ester compositions
#194Omega-3 fatty acid ester compositions
#195Ellagitannins rich extracts composition in sexual wellness
#196Co-crystals of dapagliflozin
#197Quinone based nitric oxide donating compounds
#198GLA monotherapy for use in cancer treatment
#199Ellagitannins rich extracts composition
#200Methods for pathogen detection and disease treatment
#201USE IN BRAIN DEGENERATIVE DISEASES
#202Compositions containing enriched natural crocin and/or crocetin, and their therapeutic or nutraceutical uses
#203PHARMACEUTICAL COMPOSITION FOR USE IN INHIBITING RECURRENCE, AGGRAVATION AND METASTASIS OF HEPATOCARCINOMA
#204FRUCTOSE ABSORPTION INHIBITOR
#205POLYPHOSPHATE AND PYROPHOSPHATE DERIVATIVE OF SACCHARIDES
#206Method for inhibiting autophagy of motor neurons
#207Anti-cholesterolemic compounds and methods of use
#208Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
#209Treatment to render implants resistant to diabetes
#210Method for disinfection or infection control against a non-enveloped virus
#211Methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol
#212Glufosfamide Combination Therapies for Cancer
#213Administration of eritoran or pharmaceutically acceptable salts thereof to treat orthomyxovirus infections
#214Adjuvant system for vaccine adjuvant
#215Composition for Use in the Treatment of Acne
#216Anti-Viral Azide Containing Compounds
#217Immunogenic compositions and methods for treating neoplasia
#218Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and applications thereof
#219Pharmaceutical Combination
#220Prevention and treatment of oxidative stress disorders by gluthathione and phase II detoxification enzymes
#221Composition and method of manufacture
#222NATURAL MEDICINAL COMPOUND
#223Methods of inhibition of protein fucosylation in vivo using fucose analogs
#224Recombinant human NaGlu protein and uses thereof
#225Use of synthetic polysulphated oligosaccharides as cleaning agents for a wound
#226Composition for prevention of influenza viral infection comprising tannic acid, air filter comprising the same and air cleaning device comprising the filter
#227Triterpene saponins, methods of synthesis, and uses thereof
#228PEROXIDE REMOVAL FROM DRUG DELIVERY VEHICLE
#229Treatment for gastrointestinal disorders using a selective, site-activated binding system
#230Antimicrobial system for selective, site-activated binding at target sites
#231Method of treating damaged mucosal or gastrointestinal tissue by administering a composition comprising a mixture of pomegranate and green tea extracts and releasably bound hydrogen peroxide
#232Coated balloons for blood vessel stabilization
#233THERAPEUTIC PHARMACEUTICAL AGENT FOR DISEASES ASSOCIATED WITH DECREASE IN FUNCTION OF GNE PROTEIN, FOOD COMPOSITION, AND FOOD ADDITIVE
#234DRESSING COMPRISING ACTIVE COMPONENTS OF CENTELLA ASIATICA AND USE OF THE SAME
#235Anti-bacterial infection, inflammation, and leukemia composition and use thereof
#236Elastin stabilization of connective tissue
#237TREATMENT OF CYSTIC DISEASES
#238METHOD AND COMPOSITIONS
#239Photoprotector and/or photoimmunoprotector compositions of the skin and their uses
#240Anti-viral azide containing compounds
#241Treatment of retroviral reservoirs exploiting oxidative stress
#242Triterpene saponins, methods of synthesis, and uses thereof
#243Tannate compositions, methods of making and methods of use
#244HYPERSULFATED GLUCOPYRANOSIDES
#245Synthesis of high molecular weight iron-saccharidic complexes
#246Trehalose compound, method for producing same, and pharmaceutical product containing the compound
#247STABILIZED PENTOSAN POLYSULFATE (PPS) FORMULATIONS AND METHODS OF ANALYZING THEM
#248Galactosylated pro-drugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug
#249Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
#250COMPOSITION FOR PREVENTION OF INFLUENZA VIRAL INFECTION COMPRISING TANNIC ACID, AIR FILTER COMPRISING THE SAME AND AIR CLEANING DEVICE COMPRISING THE FILTER
#251Use of sphingosine-1 phosphate (S1P) receptor agonists for the treatment of brain degenerative diseases
#252PREVENTION OF HEPATIC ISCHEMIC REPERFUSION INJURY BY ADMINISTRATION OF SULFATIDES
#253INHIBITION OF DEGRADATION OF EXTRACELLULAR MATRIX
#254METHOD FOR TREATING OBESITY
#255Methods and Compositions for the Treatment of Cystic Fibrosis and Related Illnesses
#256Compounds, compositions, and methods for protecting brain health in neurodegenerative disorders
#257Use of isothiocyanate derivatives as anti-myeloma agents
#258Protective compositions for dermal papilla cells
#259Antiviral Agent and Antiviral Composition
#260USE OF PROBIOTICS AND FIBERS FOR DIARRHOEA
#261Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
#2621-BUTANE ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES AND THE USE THEREOF
#263Anti-angiogenic extracts from pomegranate
#264COMPOSITIONS AND METHODS FOR ENHANCING TOLERANCE FOR THE PRODUCTION OF ORGANIC CHEMICALS PRODUCED BY MICROORGANISMS
#265ANTI-ALLERGEN AGENT
#266Methods for relieving asthma-associated airway hyperresponsiveness
#267ALTERNATIVE AGENT WITH VITAMIN D-LIKE ACTIVITY AND AN IMPROVING AGENT FOR INTESTINAL FUNCTION
#268Elastin stabilization of connective tissue
#269Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
#270METHOD OF INDUCING NEGATIVE CHEMOTAXIS USING AN ELLAGITANNIN OR GALLOTANNIN
#271Composition for maintaining gastrointestinal homeostasis
#272Anti-cholesterolemic compounds and methods of use
#273PHASE 2 INDUCERS AND RELATED SIGNALING PATHWAYS PROTECT CARTILAGE AGAINST INFLAMMATION/INFECTION, APOPTOSIS AND STRESS
#274MEDICAMENT FOR LCT POISONING
#275Fluid wound dressing comprising partially cured polyurethane
#276Induction of antigen specific immunnologic tolerance
#277USE OF RHAMNOLIPIDS IN WOUND HEALING, TREATING BURN SHOCK, ATHEROSCLEROSIS, ORGAN TRANSPLANTS, DEPRESSION, SCHIZOPHRENIA AND COSMETICS
#278MODULATING ANGIOGENESIS WITH NOD FACTORS SUCH AS GLUCOSAMINE OLIGOSACCHARIDES
#279Method for neutralizing fungi using sophorolipids and antifungal sophorolipids for use therein
#280USE OF SUGAR PHOSPHATES, SUGAR PHOSPHATE ANALOGS, AMINO ACIDS AND/OR AMINO ACID ANALOGS FOR MODULATING THE GLUCOLYSIS-ENZYME COMPLEX, THE MALATE ASPARATE SHUTTLE AND/OR THE TRANSAMINASES
#281Derivative of glucose and vitamin F, compositions comprising it, uses and preparation process
#282Micelles
#283Inhibition of cathepsin K activity and the treatment and prevention of disease
#284METHODS AND COMPOSITIONS FOR THERAPEUTIC TREATMENT
#285METHOD FOR TREATING OBESITY
#286METHODS AND COMPOSITIONS FOR TREATING PAIN
#287Methods and reagents for the enhancement of virus transduction in the bladder epithelium
#288Composition for maintaining gastrointestinal homeostasis
#289MANNOSYL-1 PHOSPHATES, PREPARATION METHOD AND THERAPEUTIC USE, IN PARTICULAR AGAINST THE CDG-IA SYNDROME
#290Lipase inhibitors
#291Prevention and treatment of oxidative stress disorders by glutathione and phase II detoxification enzymes
#292Method for treating obesity
#293Methods and Compositions for Enzyme-Specific Activation of Carbohydrate-Conjugated Prodrugs
#294Phenolic acid salts of gabapentin in solid dosage forms and methods of use
#295Method and reagents for the enhancement of virus transduction in the bladder epithelium
#296Compound Useful For the Prevention and Treatment of Left Ventricular Hypertrophy in Dialysed Patients
#297METHOD FOR TREATING OBESITY
#298Activators of Hexosamine Biosynthesis as Inhibitors of Injury Induced by Ischemia or Hermorrhagic Shock
#299Use of Sphingosine-1-Phosphate (S1P) Receptor Agonists For the Treatment of Brain Degenerative Diseases
#300Methods and reagents for the enhancement of virus transduction in the bladder epithelium